Community oncologists’ perceptions and utilization of large-panel genomic tumor testing

PURPOSE: Large-panel genomic tumor testing (GTT) is an emerging technology with great promise but uncertain clinical value. Previous research has documented variability in academic oncologists’ perceptions and use of GTT, but little is known about community oncologists’ perceptions of GTT and how pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Eric C., Hinton, Alexandra C., Lary, Christine W., Fenton, Anny T. H. R., Antov, Andrey, Edelman, Emily, Helbig, Petra, Reed, Kate, Miesfeldt, Susan, Thomas, Christian A., Hall, Michael J., Roberts, J. Scott, Rueter, Jens, Han, Paul K. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620967/
https://www.ncbi.nlm.nih.gov/pubmed/34823486
http://dx.doi.org/10.1186/s12885-021-08985-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620967/
https://www.ncbi.nlm.nih.gov/pubmed/34823486
http://dx.doi.org/10.1186/s12885-021-08985-0

Ejemplares similares